Average Co-Inventor Count = 8.39
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Chemocentryx, Inc. (49 from 214 patents)
2. Amgen Inc. (3 from 1,960 patents)
3. Other (1 from 832,448 patents)
53 patents:
1. 12448373 - Azetidinyl-acetamides as CXCR7 inhibitors
2. 12371433 - Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases
3. 12139475 - 2-oxindole compounds
4. 12018016 - Aryl sulfonyl (hydroxy) piperidines as CCR6 inhibitors
5. 12011439 - Combination therapy using C—C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitors
6. 11945805 - Inhibitors of CXCR2
7. 11884654 - Substituted anilines as CCR(4) antagonists
8. 11872217 - Indanes as PD-L1 inhibitors
9. 11866429 - Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases
10. 11820759 - Modulators of chemokine receptors
11. 11793771 - Immunomodulator compounds
12. 11759458 - Indane-amines as PD-L1 antagonists
13. 11713307 - Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases
14. 11708326 - Immunomodulator compounds
15. 11684606 - Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2